[IART] Integra LifeSciences Holdings Corporation

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 85.91 Change: 0.57 (0.67%)
Ext. hours: Change: 0 (0%)

chart IART

Refresh chart

Strongest Trends Summary For IART

IART is in the long-term up 319% in 14 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devi

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1% Sales Growth - Q/Q-7.34% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA2.59% ROE5.84% ROI3.02%
Current Ratio4.12 Quick Ratio2.28 Long Term Debt/Equity1.55 Debt Ratio0.18
Gross Margin62.28% Operating Margin7.77% Net Profit Margin4.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities30.45 M Cash From Investing Activities-18.74 M Cash From Operating Activities49.74 M Gross Profit157.54 M
Net Profit5 M Operating Profit13.95 M Total Assets1.64 B Total Current Assets608.25 M
Total Current Liabilities155.75 M Total Debt654.14 M Total Liabilities926.17 M Total Revenue244.08 M
Technical Data
High 52 week65.87 Low 52 week42.62 Last close61.85 Last change2.11%
RSI53.53 Average true range1.4 Beta0.67 Volume390.34 K
Simple moving average 20 days2.95% Simple moving average 50 days2.07% Simple moving average 200 days13.93%
Performance Data
Performance Week6.77% Performance Month1.76% Performance Quart14.66% Performance Half17.45%
Performance Year-3.1% Performance Year-to-date37.14% Volatility daily1.4% Volatility weekly3.13%
Volatility monthly6.42% Volatility yearly22.25% Relative Volume322.8% Average Volume416.06 K
New High New Low

News

2021-10-06 16:01:00 | Integra LifeSciences to Host Third Quarter 2021 Financial Results Conference Call on November 2, 2021

2021-09-02 16:01:00 | Integra LifeSciences Announces Participation in Upcoming Investor Conferences

2021-09-02 10:07:23 | Is It Too Late To Consider Buying Integra LifeSciences Holdings Corporation NASDAQ:IART?

2021-08-27 11:31:03 | Integra IART Up 1.5% Since Last Earnings Report: Can It Continue?

2021-08-27 09:19:01 | Here's Why You Should Retain Integra IART Stock for Now

2021-08-03 09:33:01 | Integra LifeSciences IART is a Top-Ranked Momentum Stock: Should You Buy?

2021-07-29 08:29:12 | Integra IART Q2 Earnings Top Estimates, 2021 Guidance Up

2021-07-28 14:00:41 | Integra LifeSciences Holdings Corporation IART Q2 2021 Earnings Call Transcript

2021-07-28 07:15:11 | Integra LifeSciences IART Tops Q2 Earnings and Revenue Estimates

2021-07-28 06:00:00 | Integra LifeSciences Reports Second Quarter 2021 Financial Results

2021-07-27 10:53:02 | Medical Device Stocks' Earnings on Jul 28: TMO, ALGN & More

2021-07-21 15:02:07 | Integra LifeSciences IART Earnings Expected to Grow: Should You Buy?

2021-07-20 06:59:10 | Integra IART Releases Favorable PriMatrix Clinical Outcome

2021-07-19 16:30:00 | Integra LifeSciences Announces Positive Clinical Outcomes for PriMatrix® Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers

2021-07-19 03:39:38 | Update: Integra LifeSciences Holdings NASDAQ:IART Stock Gained 70% In The Last Five Years

2021-07-15 08:27:12 | Integra's IART SurgiMend Gets Innovative Technology Contract

2021-07-14 16:30:00 | Integra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend® Collagen Matrix for Soft Tissue Reconstruction

2021-07-08 08:30:00 | Integra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021

2021-06-24 08:30:00 | Integra LifeSciences Announces CEO Succession Plan

2021-06-13 04:44:11 | Is Now The Time To Put Integra LifeSciences Holdings NASDAQ:IART On Your Watchlist?

2021-06-01 09:32:01 | Integra IART Tissue Technologies Rebounds Amid Supply Woe

2021-05-28 11:32:03 | Integra IART Down 8.1% Since Last Earnings Report: Can It Rebound?

2021-05-20 06:00:00 | Integra LifeSciences Hosts Virtual Investor Day

2021-05-08 03:59:39 | We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Integra LifeSciences Holdings Corporation's NASDAQ:IART CEO For Now

2021-05-07 08:30:00 | Integra LifeSciences to Host Virtual Investor Day on May 20, 2021

2021-04-30 10:04:02 | ResMed RMD Q3 Earnings Surpass Estimates, Revenues Miss

2021-04-30 09:29:01 | Bio-Rad BIO Q1 Earnings Surpass Estimates, Guidance Up

2021-04-30 09:01:01 | Syneos Health SYNH Q1 Earnings Top Estimates, Margins Up

2021-04-29 09:15:01 | Integra IART Hits Fresh High: Is There Still Room to Run?

2021-04-29 09:04:01 | Integra IART Q1 Earnings Beat Estimates, Gross Margin Down

2021-04-28 19:30:41 | Integra Lifesciences Holdings Corp IART Q1 2021 Earnings Call Transcript

2021-04-28 07:30:11 | Integra LifeSciences IART Q1 Earnings and Revenues Top Estimates

2021-04-28 06:45:00 | Integra LifeSciences Holdings Corp. to Host Earnings Call

2021-04-28 06:00:00 | Integra LifeSciences Reports First Quarter 2021 Financial Results

2021-04-27 08:56:12 | Medical Product Stocks' Earnings on Apr 28: BSX, ALGN & More

2021-04-22 10:59:02 | Integra IART to Report Q1 Earnings: What's in the Offing?

2021-04-20 09:49:01 | Abbott ABT Q1 Earnings Miss, Diagnostic Test Sales Solid

2021-04-20 08:09:12 | Integra IART Hits New 52-Week High: What's Driving It?

2021-04-19 16:15:00 | Integra LifeSciences Statement on the U.S. FDA Safety Communication on Acellular Dermal Matrix ADM Products Used in Implant-Based Breast Reconstruction

2021-04-08 16:00:00 | Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021

2021-04-03 05:30:56 | Is Integra LifeSciences Holdings Corporation's NASDAQ:IART 8.8% ROE Worse Than Average?

2021-04-01 16:15:00 | Integra LifeSciences Appoints Shaundra Clay as Director

2021-03-31 10:41:02 | Here's Why You Should Retain Integra LifeSciences IART Stock

2021-03-31 09:08:01 | Integra's IART Neurosurgery Rebounds Despite Supply Issues

2021-03-22 05:33:09 | Veeva VEEV Partners With Impel, Boosts Cloud-Based Offerings Revised

2021-03-20 11:30:03 | Integra IART Down 3% Since Last Earnings Report: Can It Rebound?

2021-03-10 09:24:02 | Integra IART Neurosurgery Grows Sequentially Amid Supply Woe

2021-02-25 23:36:23 | Integra LifeSciences Holdings Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

2021-02-19 08:00:00 | Integra LifeSciences Announces Participation in Upcoming Investor Conferences

2021-02-18 16:00:43 | Integra Lifesciences Holdings Corp IART Q4 2020 Earnings Call Transcript